John P. Mclaughlin's most recent trade in LENSAR Inc was a trade of 33,175 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | John P. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,175 | 33,175 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | John P. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,288 | 53,631 | - | 0 | Common Stock | |
| Rockwell Medical Inc | John P. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,857 | 72,857 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | John P. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 50,000 | 136,974 (0%) | 0% | 0 | Common Stock | |
| LENSAR Inc | John P. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 20,847 | 20,847 | - | - | Stock Option (Right to Buy) |